홈 › 폐암 › 캔자스

캔자스의 폐암 임상 시험

폐암 관련 연구 20개가 캔자스 내 여러 지역에서 참여자를 모집하고 있습니다.

캔자스의 도시

공식 연구 텍스트(영어)

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Saint Luke's South Hospital, Overland Park

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

HaysMed, Hays
Lawrence Memorial Hospital, Lawrence
The University of Kansas Cancer Center - Olathe, Olathe
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

The University of Kansas Cancer Center - Olathe, Olathe
Cancer Center of Kansas - Pratt, Pratt
Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Central Care Cancer Center - Garden City, Garden City
Central Care Cancer Center - Great Bend, Great Bend
Veteran Administration Eastern Kansas Healthcare, Leavenworth
외 4개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita
Ascension Via Christi Hospitals Wichita, Wichita
Cancer Center of Kansas - Wichita, Wichita

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT04181060

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

The University of Kansas Cancer Center - Westwood, Westwood

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

University of Kansas Clinical Research Center, Fairway
University of Kansas Cancer Center, Kansas City
University of Kansas Hospital-Indian Creek Campus, Overland Park
외 1개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06287775

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

The University of Kansas Cancer Center, Fairway

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT06244771

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

University of Kansas Clinical Research Center, Fairway
HaysMed, Hays
University of Kansas Cancer Center, Kansas City
외 7개

피험자 모집 중2상

18 Minutes · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

University of Kansas Clinical Research Center, Fairway
HaysMed, Hays
University of Kansas Cancer Center, Kansas City
외 7개

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06616584

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

University of Kansas Medical Center, Kansas City

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06343402

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

University of Kansas Cancer Center, Kansas City
University of Kansas Cancer Center-Overland Park, Overland Park

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06500481

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

University of Kansas Cancer Center, Kansas City
Lawrence Memorial Hospital, Lawrence
The University of Kansas Cancer Center - Olathe, Olathe
외 5개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05624996

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

The University of Kansas Cancer Center, Kansas City

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626

Integrated Cancer Repository for Cancer Research

Saint Luke's Cancer Instititute - South, Overland Park

피험자 모집 중관찰 연구건강한 지원자 환영

19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

The University of Kansas Cancer Center, Westwood

피험자 모집 중1/2상

18세 ~ 70세 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT05361174

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

University of Kansas Clinical Research Center, Fairway
HaysMed, Hays
University of Kansas Cancer Center, Kansas City
외 7개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Aton Health, Leawood
Ascension Via Christi Wichita, Wichita

피험자 모집 중관찰 연구

50세 이상 · 모든 성별 · 2025. 8. 5. 업데이트됨 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

University of Kansas Medical Center, Kansas City

피험자 모집 중관찰 연구

29세 ~ 85세 · 모든 성별 · 2024. 11. 13. 업데이트됨 · NCT06426628

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

The University of Kansas Cancer Center (KUCC), Fairway
The University of Kansas Cancer Center, Westwood Campus, Kansas City

피험자 모집 중관찰 연구

18세 ~ 110세 · 모든 성별 · 2024. 2. 23. 업데이트됨 · NCT05332925

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.